Tetrabenazine (marketed under the trade names Nitoman® in Canada and Xenazine® in New Zealand and some parts of Europe - also available in the USA as an orphan drug) is a dopamine-depleting drug that is closely related to the antipsychotics and works similarly, though its action is subtly different and it is not necessarily considered an antipsychotic itself.
Unlike many of the antipychotics, tetrabenazine is not known to cause Tardive dyskinesia, and in fact can be an effective treatment for the antipsychotic-induced movement disorder.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Tetrabenazine".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world